Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia

ISSN： 1040-8363

Source： Critical Reviews in Clinical Laboratory Sciences, Vol.37, Iss.5, 2000-09, pp. : 431-502

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective COX-2 Inhibitors and Risk of Myocardial Infarction

Journal of Vascular Research, Vol. 42, Iss. 4, 2005-07 ,pp. : 312-324

Karger

Access to resources Recommend Favorite

COX-2 Inhibitors for the Prevention of Breast Cancer: Advances in the Prevention of Breast Cancer

By Howe Louise R. Dannenberg Andrew J.

Journal of Mammary Gland Biology and Neoplasia, Vol. 8, Iss. 1, 2003-01 ,pp. : 31-43

Springer Publishing Company

Access to resources Recommend Favorite

Synthesis of novel pyrazolyl tetrazoles as selective COX-2 inhibitors

By Swetha Kolli Parameshwar Ravula Reddy B. babu V.

Medicinal Chemistry Research, Vol. 22, Iss. 10, 2013-10 ,pp. : 4886-4892

Springer Publishing Company

Access to resources Recommend Favorite

Review of the selective COX-2 inhibitors celecoxib and rofecoxib: focus on clinical aspects

Canadian Journal of Emergency Medicine, Vol. 4, Iss. 4, 2002-07 ,pp. : 268-275

Cambridge University Press

Access to resources Recommend Favorite

Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?

By Hersh Elliot V. Lally Edward T. Moore Paul A.

Current Medical Research and Opinion, Vol. 21, Iss. 8, 2005-08 ,pp. : 1217-1226

Informa Healthcare

Access to resources Recommend Favorite